
| Serial Number | 79392969 |
| Word Mark | GLOBAL DAO CONGRESS |
| Filing Date | Tuesday, February 27, 2024 |
| Status | 401 - IR CANCELLED - NO TRANSFORMATION FILED |
| Status Date | Friday, February 7, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Seminar, congress and course organization services; organization of fairs and/or exhibitions of a training and/or cultural nature |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Wednesday, November 6, 2024 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | DR. HEALTHCARE ESPAÑA, S.L. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Event Date | Event Description |
| Monday, April 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, September 14, 2024 | ASSIGNED TO EXAMINER |
| Thursday, April 4, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, April 12, 2024 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, September 25, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, September 26, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, September 30, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, September 30, 2024 | REFUSAL PROCESSED BY MPU |
| Saturday, November 2, 2024 | REFUSAL PROCESSED BY IB |
| Saturday, November 23, 2024 | DEATH OF INTERNATIONAL REGISTRATION |
| Saturday, September 27, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, September 3, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 3, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |